
The Iran campaign consumption rate directly constrains Pacific Command's air defense loadouts for a Taiwan scenario.
If INDOPACOM requires 300+ terminal-phase interceptors forward-deployed and production supplies only 50–60 per quarter, the inventory deficit forces either acceptance of higher attrition risk in a Taiwan conflict or diversion of Middle East assets — a choice that converts air defense stockpile levels into a geopolitical lever.
Raytheon's margin pressure on SM-6 production (cited in prior signals on FY27 budget surges) means the 225% increase may not materialize on schedule, extending the gap into the 2028–2029 window when China's hypersonic threat matures.
This reveals a critical inventory constraint: sustained high-intensity air defense operations against a peer or near-peer adversary burn through terminal-phase interceptors at rates that existing production and stockpiles cannot sustain in parallel theaters.
If the US faces a Taiwan contingency while maintaining Middle East operations, Raytheon and Lockheed Martin's SM-2/SM-3 production (currently ~200–250 units annually across all variants) becomes a hard constraint on simultaneous force projection.
The FY27 budget request for 225% more SM-6s signals Pentagon recognition of this gap, but procurement lead times (24–36 months for production ramp) mean current inventory remains the binding constraint through 2027–2028. Operators in INDOPACOM and CENTCOM will compete for the same pool.
The article does not specify which interceptor variants were expended (SM-2, SM-3, SM-6 breakdown), nor does it clarify whether the 100–150 figure includes lower-tier systems (CIWS, SHORAD), which would materially change the strategic implication for high-end air defense gaps.
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.